ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
Ian
I
Morrissey
Don
D
Biek
Regina
R
Janes
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000382:microbiology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D015780:Carbapenems / Q000494:pharmacology*; D017714:Community-Acquired Infections / Q000150:complications / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000150:complications / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D015780:Carbapenems; C490527:ME1036